Prevalence, Deaths and Disability-Adjusted-Life-Years (DALYs) Due to Type 2 Diabetes and Its Attributable Risk Factors in 204 Countries and Territories, 1990-2019: Results From the Global Burden of Disease Study 2019

Saeid Safiri, Ali‐Asghar Kolahi(Shahid Beheshti University of Medical Sciences), Jay S. Kaufman(McGill University), Maziar Moradi‐Lakeh(Iran University of Medical Sciences), Gary S. Collins(Nuffield Orthopaedic Centre), Mark J. M. Sullman(University of Nicosia), Arielle Wilder Bell(Northwestern University), Seyed Aria Nejadghaderi(Tabriz University of Medical Sciences), Nahid Karamzad(Tabriz University of Medical Sciences)
Frontiers in Endocrinology
February 25, 2022
10.3389/fendo.2022.838027
Cited by 247

Related Papers

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
|The Lancet|2016|7.8k
Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal
|BMJ|2020|3.2k
The Global Burden of Cancer 2013
|JAMA Oncology|2015|2.8k
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
|The Lancet|2015|2.7k
The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level
|JAMA Oncology|2017|2k